Oxford Health NHS Foundation Trust
13
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Self-compassion and Quality of Life After Dementia Diagnosis
Role: lead
Stratification and Treatment in Early Psychosis Study -ASSIST
Role: collaborator
Stratification and Treatment in Early Psychosis Study - ENHANCE
Role: collaborator
Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT)
Role: lead
Eating Disorders Clinical Research Network
Role: collaborator
An Investigation of Levetiracetam in Alzheimer's Disease
Role: collaborator
Compassion Project: Developing an Empathy-Based Stress Intervention
Role: collaborator
Evaluation of a Rumination Intervention for Individuals With PTSD: A Case Series
Role: collaborator
Fluid Restriction and Quality of Life on Dialysis
Role: collaborator
Lithium Versus Quetiapine in Treatment Resistant Depression
Role: collaborator
Guided Self-help for Binge Eating
Role: lead
Enhanced Care Home Outcomes: A Qualitative Study
Role: lead
MAPP: Imagery-focused Therapy for Bipolar Disorder
Role: collaborator
All 13 trials loaded